Brief: Galmed Reports Significant Anti-Fibrotic Effects Of Aramchol In A Lung Fibrosis Model

Eocene

07/07/2022 13:29

July 7 (Reuters) - Galmed Pharmaceuticals Ltd  GLMD.O :
    * GALMED REPORTS SIGNIFICANT ANTI-FIBROTIC EFFECTS OF
ARAMCHOL IN
A LUNG FIBROSIS MODEL
    * GALMED PHARMACEUTICALS - STATISTICALLY SIGNIFICANT
CLINICAL AND
HISTOLOGY IMPROVEMENTS WERE ALSO DEMONSTRATED IN A MODEL OF
INFLAMMATORY BOWEL DISEASE
    * GALMED PHARMACEUTICALS LTD - GALMED CONTINUES TO ASSESS
ARAMCHOL'S ANTI-FIBROTIC EFFECTS ALSO IN KIDNEY AND SKIN

Source text for Eikon:  ID:nPn6Dd3q6a 
Further company coverage:  GLMD.O